BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201203T090000
DTEND;TZID=America/Vancouver:20201203T103000
DTSTAMP:20201117T182631Z
CREATED:20201117T182631Z
LAST-MODIFIED:20201117T182631Z
UID:13585-1606986000-1606991400@scienceinvancouver.com
SUMMARY:Toward the Horizon: How COVID-19 Is Accelerating Innovation in Pharmaceutical and Life Sciences Analytics
DESCRIPTION:The life sciences industry thrives on innovation\, so it’s no surprise that COVID-19 is rapidly driving inventive analytics solutions to address key challenges posed by the crisis. In this session\, we’ll explore the impact of the pandemic on pharmaceutical manufacturers and the resulting acceleration of digitization as the industry responds and adapts. \nLife sciences companies are taking advantage of digital health and virtual trial methodologies to mitigate delays in clinical research. They are using epidemiological modelling to study and predict the potential for using real-world data to gather evidence for COVID-19 therapies. They are evolving their sales and marketing strategies to optimize the overnight shift to digital channels to connect with prescribers. Finally\, SAS experts will share perspective on lessons learned and the road ahead. \nConfirmed Speakers \n\nSherrine Eid\, Principal Industry Consultant – SAS\nPatrick Homer\, Advisory Industry Consultant – SAS\nMark Lambrecht\, Director – SAS\nStijn Rogiers\, Principal Industry Consultant – SAS\n\nEvent Details \nDate: Thursday\, December 3\, 2020 \nTime: 9:00 – 10:30 AM \nTickets: Free for everyone \nAgenda:  \n9:00 AM – Welcome and Introduction \n9:10 AM – Presentations Start \n10:10 AM – Q&A Period
URL:https://scienceinvancouver.com/event/toward-the-horizon-how-covid-19-is-accelerating-innovation-in-pharmaceutical-and-life-sciences-analytics/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/11/https___cdn.evbuc_.com_images_117357009_214018703909_1_original.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201203T090000
DTEND;TZID=America/Vancouver:20201203T103000
DTSTAMP:20201117T182631Z
CREATED:20201117T182631Z
LAST-MODIFIED:20201117T182631Z
UID:26300-1606986000-1606991400@scienceinvancouver.com
SUMMARY:Toward the Horizon: How COVID-19 Is Accelerating Innovation in Pharmaceutical and Life Sciences Analytics
DESCRIPTION:The life sciences industry thrives on innovation\, so it’s no surprise that COVID-19 is rapidly driving inventive analytics solutions to address key challenges posed by the crisis. In this session\, we’ll explore the impact of the pandemic on pharmaceutical manufacturers and the resulting acceleration of digitization as the industry responds and adapts. \nLife sciences companies are taking advantage of digital health and virtual trial methodologies to mitigate delays in clinical research. They are using epidemiological modelling to study and predict the potential for using real-world data to gather evidence for COVID-19 therapies. They are evolving their sales and marketing strategies to optimize the overnight shift to digital channels to connect with prescribers. Finally\, SAS experts will share perspective on lessons learned and the road ahead. \nConfirmed Speakers \n\nSherrine Eid\, Principal Industry Consultant – SAS\nPatrick Homer\, Advisory Industry Consultant – SAS\nMark Lambrecht\, Director – SAS\nStijn Rogiers\, Principal Industry Consultant – SAS\n\nEvent Details \nDate: Thursday\, December 3\, 2020 \nTime: 9:00 – 10:30 AM \nTickets: Free for everyone \nAgenda:  \n9:00 AM – Welcome and Introduction \n9:10 AM – Presentations Start \n10:10 AM – Q&A Period
URL:https://scienceinvancouver.com/event/toward-the-horizon-how-covid-19-is-accelerating-innovation-in-pharmaceutical-and-life-sciences-analytics-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/11/https___cdn.evbuc_.com_images_117357009_214018703909_1_original.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201203T090000
DTEND;TZID=America/Vancouver:20201203T103000
DTSTAMP:20201117T182631Z
CREATED:20201117T182631Z
LAST-MODIFIED:20201117T182631Z
UID:27915-1606986000-1606991400@scienceinvancouver.com
SUMMARY:Toward the Horizon: How COVID-19 Is Accelerating Innovation in Pharmaceutical and Life Sciences Analytics
DESCRIPTION:The life sciences industry thrives on innovation\, so it’s no surprise that COVID-19 is rapidly driving inventive analytics solutions to address key challenges posed by the crisis. In this session\, we’ll explore the impact of the pandemic on pharmaceutical manufacturers and the resulting acceleration of digitization as the industry responds and adapts. \nLife sciences companies are taking advantage of digital health and virtual trial methodologies to mitigate delays in clinical research. They are using epidemiological modelling to study and predict the potential for using real-world data to gather evidence for COVID-19 therapies. They are evolving their sales and marketing strategies to optimize the overnight shift to digital channels to connect with prescribers. Finally\, SAS experts will share perspective on lessons learned and the road ahead. \nConfirmed Speakers \n\nSherrine Eid\, Principal Industry Consultant – SAS\nPatrick Homer\, Advisory Industry Consultant – SAS\nMark Lambrecht\, Director – SAS\nStijn Rogiers\, Principal Industry Consultant – SAS\n\nEvent Details \nDate: Thursday\, December 3\, 2020 \nTime: 9:00 – 10:30 AM \nTickets: Free for everyone \nAgenda:  \n9:00 AM – Welcome and Introduction \n9:10 AM – Presentations Start \n10:10 AM – Q&A Period
URL:https://scienceinvancouver.com/event/toward-the-horizon-how-covid-19-is-accelerating-innovation-in-pharmaceutical-and-life-sciences-analytics-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/11/https___cdn.evbuc_.com_images_117357009_214018703909_1_original.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201203T090000
DTEND;TZID=America/Vancouver:20201203T103000
DTSTAMP:20201117T182631Z
CREATED:20201117T182631Z
LAST-MODIFIED:20201117T182631Z
UID:30998-1606986000-1606991400@scienceinvancouver.com
SUMMARY:Toward the Horizon: How COVID-19 Is Accelerating Innovation in Pharmaceutical and Life Sciences Analytics
DESCRIPTION:The life sciences industry thrives on innovation\, so it’s no surprise that COVID-19 is rapidly driving inventive analytics solutions to address key challenges posed by the crisis. In this session\, we’ll explore the impact of the pandemic on pharmaceutical manufacturers and the resulting acceleration of digitization as the industry responds and adapts. \nLife sciences companies are taking advantage of digital health and virtual trial methodologies to mitigate delays in clinical research. They are using epidemiological modelling to study and predict the potential for using real-world data to gather evidence for COVID-19 therapies. They are evolving their sales and marketing strategies to optimize the overnight shift to digital channels to connect with prescribers. Finally\, SAS experts will share perspective on lessons learned and the road ahead. \nConfirmed Speakers \n\nSherrine Eid\, Principal Industry Consultant – SAS\nPatrick Homer\, Advisory Industry Consultant – SAS\nMark Lambrecht\, Director – SAS\nStijn Rogiers\, Principal Industry Consultant – SAS\n\nEvent Details \nDate: Thursday\, December 3\, 2020 \nTime: 9:00 – 10:30 AM \nTickets: Free for everyone \nAgenda:  \n9:00 AM – Welcome and Introduction \n9:10 AM – Presentations Start \n10:10 AM – Q&A Period
URL:https://scienceinvancouver.com/event/toward-the-horizon-how-covid-19-is-accelerating-innovation-in-pharmaceutical-and-life-sciences-analytics-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/11/https___cdn.evbuc_.com_images_117357009_214018703909_1_original.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201203T090000
DTEND;TZID=America/Vancouver:20201203T103000
DTSTAMP:20201117T182631Z
CREATED:20201117T182631Z
LAST-MODIFIED:20201117T182631Z
UID:32458-1606986000-1606991400@scienceinvancouver.com
SUMMARY:Toward the Horizon: How COVID-19 Is Accelerating Innovation in Pharmaceutical and Life Sciences Analytics
DESCRIPTION:The life sciences industry thrives on innovation\, so it’s no surprise that COVID-19 is rapidly driving inventive analytics solutions to address key challenges posed by the crisis. In this session\, we’ll explore the impact of the pandemic on pharmaceutical manufacturers and the resulting acceleration of digitization as the industry responds and adapts. \nLife sciences companies are taking advantage of digital health and virtual trial methodologies to mitigate delays in clinical research. They are using epidemiological modelling to study and predict the potential for using real-world data to gather evidence for COVID-19 therapies. They are evolving their sales and marketing strategies to optimize the overnight shift to digital channels to connect with prescribers. Finally\, SAS experts will share perspective on lessons learned and the road ahead. \nConfirmed Speakers \n\nSherrine Eid\, Principal Industry Consultant – SAS\nPatrick Homer\, Advisory Industry Consultant – SAS\nMark Lambrecht\, Director – SAS\nStijn Rogiers\, Principal Industry Consultant – SAS\n\nEvent Details \nDate: Thursday\, December 3\, 2020 \nTime: 9:00 – 10:30 AM \nTickets: Free for everyone \nAgenda:  \n9:00 AM – Welcome and Introduction \n9:10 AM – Presentations Start \n10:10 AM – Q&A Period
URL:https://scienceinvancouver.com/event/toward-the-horizon-how-covid-19-is-accelerating-innovation-in-pharmaceutical-and-life-sciences-analytics-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/11/https___cdn.evbuc_.com_images_117357009_214018703909_1_original.jpg
END:VEVENT
END:VCALENDAR